Laddar...
FGFR1 is an adverse outcome indicator for luminal A breast cancers
Fibroblast growth factor receptor 1 (FGFR1) has been suggested to be the candidate gene for 8p11–12 amplification in breast cancer and its therapeutic/prognostic value is explored. Most previous studies focused on FGFR1 gene amplification, which may not necessarily lead to protein expression. Theref...
Sparad:
| I publikationen: | Oncotarget |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Impact Journals LLC
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4826266/ https://ncbi.nlm.nih.gov/pubmed/26673008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6563 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|